ALZHEIMER NEUROFIBRILLARY LESIONS - MOLECULAR NATURE AND POTENTIAL ROLES OF DIFFERENT COMPONENTS

被引:48
作者
YEN, SH
LIU, WK
HALL, FL
YAN, SD
STERN, D
DICKSON, DW
机构
[1] CHILDRENS HOSP,DIV ORTHOPAED SURG,LOS ANGELES,CA 90054
[2] COLUMBIA UNIV,COLL PHYS & SURG,DEPT PHYSIOL,NEW YORK,NY 10032
关键词
NEUROFIBRILLARY LESIONS; PHF-TAU;
D O I
10.1016/0197-4580(95)00022-7
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Neurofibrillary lesions found in Alzheimer disease (AD) are known to react with antibodies raised against different molecules. At least 20 components have been detected in neurofibrillary tangles. These components can be roughly categorized into five groups, which include structural proteins, kinases and other cytosolic enzymes, stress-related molecules, amyloid and amyloid binding proteins, and others. Among them, an abnormal form of microtubule associated protein tau, PHF-tau, is a major component of Alzheimer NFT. Kinases associated with NFT, especially those belonging to the family of proline-directed Ser/Thr kinases, are considered to be important for PHF-tau hyperphosphorylation. A potentially significant kinase is a Cdc2-related kinase, which is associated tightly with paired helical filaments, has a molecular weight of 33kDa and is different from other known Cdc2-related kinases. The possibility that some of the NFT-associated elements may play an active role in the pathogenesis of Alzheimer's disease was supported by recent studies, in which advanced glycated products and markers of oxidant stress were located in NFT. In addition, PHF-tau was found to be glycated, and in vitro glycated tau was capable of inducing oxidant stress. Further characterization of different components of NFT by biochemical and other approaches will be important for understanding the mechanisms involved in the supramolecular aggregation of PI-IF within NFT.
引用
收藏
页码:381 / 387
页数:7
相关论文
共 92 条
[51]  
LINDWALL G, 1984, J BIOL CHEM, V259, P5301
[52]   APPLICATION OF SYNTHETIC PHOSPHO-PEPTIDES AND UNPHOSPHO-PEPTIDES TO IDENTIFY PHOSPHORYLATION SITES IN A SUBREGION OF THE TAU-MOLECULE, WHICH IS MODIFIED IN ALZHEIMERS-DISEASE [J].
LIU, WK ;
MOORE, WT ;
WILLIAMS, RT ;
HALL, FL ;
YEN, SH .
JOURNAL OF NEUROSCIENCE RESEARCH, 1993, 34 (03) :371-376
[53]  
LIU WK, 1993, AM J PATHOL, V142, P387
[54]  
LIU WK, 1995, AM J PATHOL, V146, P228
[55]  
LIU WK, 1991, J BIOL CHEM, V266, P21723
[56]  
LIU WK, 1994, J NEUROCHEM, V62, P1055
[57]   GLYCOGEN-SYNTHASE KINASE-3 AND THE ALZHEIMER-LIKE STATE OF MICROTUBULE-ASSOCIATED PROTEIN TAU [J].
MANDELKOW, EM ;
DREWES, G ;
BIERNAT, J ;
GUSTKE, N ;
VANLINT, J ;
VANDENHEEDE, JR ;
MANDELKOW, E .
FEBS LETTERS, 1992, 314 (03) :315-321
[58]  
MAWALDEWAN M, 1992, J BIOL CHEM, V267, P19705
[59]   ACTIVATION OF THE CLASSICAL COMPLEMENT PATHWAY IN BRAIN-TISSUE OF ALZHEIMER PATIENTS [J].
MCGEER, PL ;
AKIYAMA, H ;
ITAGAKI, S ;
MCGEER, EG .
NEUROSCIENCE LETTERS, 1989, 107 (1-3) :341-346
[60]   A FAMILY OF HUMAN CDC2-RELATED PROTEIN-KINASES [J].
MEYERSON, M ;
ENDERS, GH ;
WU, CL ;
SU, LK ;
GORKA, C ;
NELSON, C ;
HARLOW, E ;
TSAI, LH .
EMBO JOURNAL, 1992, 11 (08) :2909-2917